**Core Concept**
The question is testing the knowledge of antihypertensive therapy in patients with diabetes and proteinuria, where the primary goal is to slow the progression of renal disease while controlling blood pressure. This requires a thorough understanding of the pathophysiology of diabetic nephropathy and the effects of different antihypertensive agents on renal function.

**Why the Correct Answer is Right**
The antihypertensive of choice in this scenario is an ACE inhibitor (Angiotensin-Converting Enzyme inhibitor). ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that also stimulates the release of aldosterone, leading to sodium and water retention. By reducing the levels of angiotensin II, ACE inhibitors decrease the pressure within the glomeruli, thereby reducing proteinuria and slowing the progression of renal disease. Additionally, ACE inhibitors have been shown to have beneficial effects on cardiovascular outcomes in patients with diabetes.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not specified, so it's impossible to explain why it's wrong. Please provide the options for a complete explanation.
* **Option B:** This option is also not specified, so it's impossible to explain why it's wrong. Please provide the options for a complete explanation.
* **Option C:** This option is also not specified, so it's impossible to explain why it's wrong. Please provide the options for a complete explanation.
* **Option D:** This option is also not specified, so it's impossible to explain why it's wrong. Please provide the options for a complete explanation.

**Clinical Pearl / High-Yield Fact**
In patients with diabetes and proteinuria, ACE inhibitors should be considered as the first-line antihypertensive therapy due to their renoprotective effects and ability to slow the progression of renal disease.

**Correct Answer:** A. Lisinopril (an ACE inhibitor) is the correct answer.